Cargando…
Circadian, Week-to-Week, and Physical Exercise-Induced Variation of Serum Microfibrillar-Associated Protein 4
Serum microfibrillar-associated protein 4 (sMFAP4) has been investigated as a biomarker for various diseases and is demonstrated to show significant gradual increase with severity of liver fibrosis. Ideal biomarkers used for disease diagnosis or prognosis should display deviating levels in affected...
Autores principales: | Sækmose, Susanne Gjørup, Holst, René, Lottenburger, Tine, Ytting, Henriette, Nielsen, Hans Jørgen, Junker, Peter, Schlosser, Anders, Sorensen, Grith Lykke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127734/ https://www.ncbi.nlm.nih.gov/pubmed/34035648 http://dx.doi.org/10.1177/11772719211016359 |
Ejemplares similares
-
Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2015) -
Enzyme-Linked Immunosorbent Assay Characterization of Basal Variation and Heritability of Systemic Microfibrillar-Associated Protein 4
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2013) -
Localization of Microfibrillar-Associated Protein 4 (MFAP4) in Human Tissues: Clinical Evaluation of Serum MFAP4 and Its Association with Various Cardiovascular Conditions
por: Wulf-Johansson, Helle, et al.
Publicado: (2013) -
Microfibrillar-associated protein 4 variation in symptomatic peripheral artery disease
por: Hemstra, Line Ea, et al.
Publicado: (2018) -
Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients
por: Johansson, Sofie Lock, et al.
Publicado: (2019)